<p>The present invention is directed to a compound falling under Structural Formula (A):
or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.</p>
申请公布号
HK1155150(A1)
申请公布日期
2014.02.14
申请号
HK20110109457
申请日期
2011.09.07
申请人
TETRAPHASE PHARMACEUTICALS INC.
发明人
ZHOU, JINGYE;XIAO, XIAO-YI;PLAMONDON, LOUIS;HUNT, DIANA, KATHARINE;CLARK, ROGER, B.;ZAHLER, ROBERT, B.
